About
ConveloTx develops patented therapies that enhance remyelination in the central nervous system to promote repair and regeneration for patients with multiple sclerosis.
Explore ConveloTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.